Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Transoesophageal echocardiography improves fibrillation outcome:

This article was originally published in Clinica

Executive Summary

Transoesophageal echocardiography improves outcome in fibrillation patients, according to a study in the Journal of the American College of Cardiology (May). Researchers from Beth Israel Hospital, Boston, used transoesophageal echo to check for clotting in 230 atrial fibrillation patients in a prospective, consecutive study. Thromboembolism is a major cause of complication and death in this group of patients. The team identified clots in 34 patients, who went on to prolonged anticoagulation. The remaining 196 patients were successfully converted to sinus rhythm.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT091719

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel